Clarithromycin lactobionate
| CAS No. | 135326-55-5 | Cat. No. | BCP13837 |
| Name | Clarithromycin lactobionate | ||
| Synonyms | Abbott-56268; A-56268;Abbott56268; A56268;Abbott 56268; A 56268; | ||
| Formula | C50H89NO24 | M. Wt | 1088.24 |
| Description | Clarithromycin is an antibiotic used to treat various bacterial infections. This includes strep throat, pneumonia, skin infections, H. pylori infection, and Lyme disease, among others. Clarithromycin was developed in 1980. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. Clarithromycin prevents bacteria by acting as a protein synthesis inhibitor. It binds to 23S rRNA, a component of the 50S subunit of the bacterial ribosome, thus inhibiting the translation of peptides. | ||
| Pathways | Microbiology/Virology | ||
| Targets | Antibiotic | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.